A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
How Longford Capital protects university IP
GUV speaks with William Farrell of Longford Capital about the firm’s $500m litigation finance fund.
UA targets pain with Regulonix
The Arizona spinout is searching for non-opioid painkillers that target sections of the nerve cell membrane thought responsible for pain disorders.
Reglagene shortens cancer cell life
The spinout will develop research on drugs that could one day shorten the lifespan of cancerous cells.
Hebrew University and Fraunhofer screen accelerator
The two institutions have chosen 16 cybersecurity teams from Israel and Germany to receive almost three months of training.
Riverfield operates $10.1m series B
The Tokyo Institute of Technology spinout has raised $10.1m to continue development of its medical robot that assist surgeons during delicate procedures.
Cronin investigates OpenIOLabs for $615,000
OpenIOLabs has been bought by diversified scientific research firm Cronin in a $615,000 all-shares deal.
Edinburgh hits it off with Mercia
Mercia Technologies has signed a partnership agreement with University of Edinburgh to help commercialise research emerging from the institution.
Kano builds $28m series B
Stanford Engineering Venture Fund has backed a series B round for Kano, which will use the money to start selling its computer kits in the US.
LambdaVision grows with series A
The University of Connecticut spinout has received $500,000 from state-owned firm Connecticut Innovations, and will now advance R&D on its protein-coated implant for eye diseases.
Olsson steps down from Karolinska Development
Hans-Olov Olsson has resigned from Karolinska Development’s board of directors just over half a year after being appointed, and is likely to be replaced by Ewa Björling.
Level Ex grades $11m series A
Level Ex will use the funding round, led by 4490 Ventures, to scale up its computer game-like approach to teaching physicians’ surgical skills.
CyRise installs first cohort
The Deakin University-backed accelerator has selected the first startups to join its program.
ABLS IV targets autoimmune diseases
The Cornell University spinout will look at inhibitor drugs that could better fight autoimmune and inflammatory diseases.
Csiro kicks off innovation fund
Spinouts developing products ranging from troubleshooting for quantum computers to energy efficient wifi devices will be supported by the innovation fund.
Concept models Aquila acquisition
UK-based drug research spinout Aquila Biomedical has been purchased by Concept Life Sciences, which hopes to enhance its own service offering to multiple scientific industries.
Gemini stars in $42.5m series A
The ophthalmology-focused precision medicine developer has licensed research from several universities, including Edinburgh.
